A growth equity firm that invests in companies that are commercializing high-margin life sciences products.
HighCape partners (“HighCape”) is a growth equity firm that invests in companies that are commercializing high-margin life sciences products. They transform Their portfolio companies into scalable commercial entities (SCEs), allowing them to become sustainable businesses with multiple exit alternatives.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jun 14, 2017
Aziyo Biologics
|
Series Unknown | $12M | Biotechnology | Yes |